Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.
Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the ClinicalTrials.gov page. The core study details remain unchanged.SummaryDifference0.0%
- Check13 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check21 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page.SummaryDifference0.3%
- Check35 days agoChange DetectedOnly minor UI/layout adjustments to headers and page structure are evident, with no substantive changes to study details (title, purpose, endpoints, eligibility criteria, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check63 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference3%
- Check71 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.